These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 21385990

  • 21. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R.
    Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
    [Abstract] [Full Text] [Related]

  • 22. [Isolation and identification of cancer stem cells from primary human ovarian cancer tissues].
    Lin S, Long HX, Xiang T, Zhu B, Xie RK.
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):896-9. PubMed ID: 22340097
    [Abstract] [Full Text] [Related]

  • 23. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R, Wu Q, Liu F, Wang Y.
    Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
    Wei C, Guomin W, Yujun L, Ruizhe Q.
    Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
    [Abstract] [Full Text] [Related]

  • 31. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    Zhou J, Wang H, Cannon V, Wolcott KM, Song H, Yates C.
    Mol Cancer; 2011 Sep 14; 10():112. PubMed ID: 21917149
    [Abstract] [Full Text] [Related]

  • 32. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
    Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY.
    Gastroenterology; 2007 Jun 14; 132(7):2542-56. PubMed ID: 17570225
    [Abstract] [Full Text] [Related]

  • 33. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
    Choi SA, Wang KC, Phi JH, Lee JY, Park CK, Park SH, Kim SK.
    Cancer Lett; 2012 Nov 28; 324(2):221-30. PubMed ID: 22652175
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.
    J Neurosurg; 2011 Mar 28; 114(3):651-62. PubMed ID: 21054139
    [Abstract] [Full Text] [Related]

  • 38. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
    Yang Q, Zhang T, Wang C, Jiao J, Li J, Deng Y.
    Eur J Pharm Biopharm; 2014 Nov 28; 88(3):737-45. PubMed ID: 25460146
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
    Shi CJ, Gao J, Wang M, Wang X, Tian R, Zhu F, Shen M, Qin RY.
    World J Gastroenterol; 2011 Jun 28; 17(24):2965-71. PubMed ID: 21734809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.